INEX 2026

Innovation Catalogue

NutriQuad Pastille: A 3D-Printed Multi-Bioactive Nutraceutical Pastille.

Industry 4.0

NutriQuad Pastille is a proposed multi-ingredient nutraceutical dosage form that combines four plant-derived bioactive components—curcumin, allicin, polyphenols and quercetin—in a convenient pastille format produced using 3D-printing technology. The concept aims to bring together the antioxidant and other reported biological properties of these ingredients in a patient-friendly, customizable dosage form. 3D printing may enable control over the shape, dimensions, mass and internal structure of ea

Innovator(s)
Mrs. Peddapaka Jagruthi, Dr. Kiranmai Mandava
Organisation
St. Paul’s College of Pharmacy, Hyderabad, Telangana, India.
Country
India
Exhibition zone
Product Arena
Technology Readiness Level
TRL 4 of 9
Edition
INEX 2026

About this innovation

The proposed work focuses on the formulation and development of NutriQuad, an innovative multi-bioactive nutraceutical pastille incorporating four selected natural bioactive components: Curcumin, Allicin, Polyphenols and Quercetin. The project aims to integrate natural bioactive ingredients with advanced pharmaceutical 3D-printing technology to develop a convenient, customizable and quality-evaluated nutraceutical dosage form. The concept explores the potential of combining multiple plant-derived bioactive compounds in a single formulation while addressing important challenges associated with conventional nutraceutical products, including taste, solubility, stability, ingredient compatibility and dose uniformity.

The formulation involves the selection and incorporation of Curcumin, derived from turmeric, Allicin, obtained from garlic, Polyphenols from suitable plant-derived sources, and Quercetin, a naturally occurring flavonoid. These ingredients are selected based on their reported antioxidant, anti-inflammatory and other biological properties. The formulation also incorporates suitable excipients such as starch, gelatin, glycerol, sorbitol, date syrup, lemon juice, beetroot juice and purified water to obtain an appropriate semi-solid consistency, texture and printable formulation matrix.The preparation process involves the development of separate formulation phases, including the hydration of gelatin and preparation of starch paste under controlled heating conditions. The selected bioactive ingredients are subsequently incorporated into the formulation matrix with continuous mixing to achieve a uniform semi-solid mass. The prepared formulation is then transferred into a suitable extrusion cartridge and loaded into a pharmaceutical 3D printer. Using a predefined digital design and optimized printing parameters, the formulation is deposited layer by layer to produce pastilles of the desired shape and dimensions. The printed pastilles are dried under controlled conditions and packed in suitable airtight containers to protect them from environmental moisture and other storage-related factors.

The developed NutriQuad pastilles are subjected to systematic post-formulation evaluation to determine their physicochemical characteristics and quality attributes. The evaluation includes appearance, weight variation, dimensions, hardness, friability where applicable, moisture content, content uniformity, disintegration time and dissolution behaviour. Appropriate analytical methods are also considered to assess the stability and compatibility of the selected bioactive ingredients. In-vitro antioxidant and antimicrobial studies may be performed to investigate selected biological properties of the formulation.

A major innovative aspect of this work is the application of 3D-printing technology in nutraceutical formulation development. Unlike conventional manufacturing approaches, additive manufacturing offers flexibility in designing dosage-form geometry, adjusting printing parameters and exploring customized unit production. The technology may also facilitate systematic optimization of formulation composition, extrusion characteristics and reproducibility of printed units.The project further explores the possibility of sustainable formulation development through the selection of suitable naturally derived excipients, efficient material utilization and potential biodegradable packaging alternatives. Its future scope includes formulation optimization, stability enhancement, scale-up studies, toxicological assessment and evaluation of biological activities using appropriate experimental models.

Overall, NutriQuad represents an interdisciplinary pharmaceutical innovation combining natural bioactive ingredients, nutraceutical formulation science and 3D-printing technology. The proposed work aims to establish the feasibility of producing customized, convenient and quality-assessed multi-bioactive pastilles with potential applications in nutraceutical research and development. Further experimental and clinical investigations would be necessary to establish their safety, efficacy and any specific health benefits. The formulation is an investigational research concept and is not intended to replace approved treatments for leishmaniasis or other diseases.

Watch the video